Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

OBJECTIVES: To report the effect of different imputation methodologies on the assessment of radiographic progression in clinical trials. METHODS: The 216-week RAPID-psoriatic arthritis (PsA) (NCT01087788) trial of certolizumab pegol (CZP) in patients with active PsA was double-blind and placebo-cont...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, D, Fleischmann, R, Wollenhaupt, J, Deodhar, A, Kielar, D, Woltering, F, Stach, C, Hoepken, B, Arledge, T, Mease, P J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888591/
https://www.ncbi.nlm.nih.gov/pubmed/23942869
http://dx.doi.org/10.1136/annrheumdis-2013-203697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888591/
https://www.ncbi.nlm.nih.gov/pubmed/23942869
http://dx.doi.org/10.1136/annrheumdis-2013-203697

Ejemplares similares